NVX-CoV2540

Drug identity checked against registry records

Also recorded as Omicron BA.5 SARS-CoV-2 rS /Matrix-M Adjuvant

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
Phase 3 Boosting Study for the SARS-CoV-2 rS Variant VaccinesNCT05372588NovavaxPhase 3Completed2022-07-17Actual

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.